These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 20430304

  • 21. Guidance on the diagnosis and clinical management of psoriasis.
    Cohen SN, Baron SE, Archer CB, British Association of Dermatologists and Royal College of General Practitioners.
    Clin Exp Dermatol; 2012 May; 37 Suppl 1():13-8. PubMed ID: 22486764
    [Abstract] [Full Text] [Related]

  • 22. Psoriasis: disease management with a brief review of new biologics.
    Khachemoune A, Guillen S.
    Dermatol Nurs; 2006 Feb; 18(1):40-3, 49. PubMed ID: 16550896
    [Abstract] [Full Text] [Related]

  • 23. Biologic therapy with or without topical treatment in psoriasis: what does the current evidence say?
    Jensen JD, Delcambre MR, Nguyen G, Sami N.
    Am J Clin Dermatol; 2014 Oct; 15(5):379-85. PubMed ID: 25027461
    [Abstract] [Full Text] [Related]

  • 24. [The therapeutic activity of Cutivate in the treatment of inflammatory skin diseases].
    Trubin VP, Dubinin VP, Glad'ko OV, Volkova OA.
    Voen Med Zh; 2000 Mar; 321(3):36-8. PubMed ID: 10815538
    [No Abstract] [Full Text] [Related]

  • 25. Long-term data in the treatment of psoriasis.
    Thaçi D.
    Br J Dermatol; 2008 Aug; 159 Suppl 2():18-24. PubMed ID: 18700911
    [Abstract] [Full Text] [Related]

  • 26. [Psoriasis].
    el Sayed F, Marguery MC.
    Ann Dermatol Venereol; 1997 Aug; 124(1):91-101. PubMed ID: 9686048
    [No Abstract] [Full Text] [Related]

  • 27. Psoriasis: maximizing topical treatment concordance.
    Gupta G, Bhattacharya S.
    Br J Hosp Med (Lond); 2007 May; 68(5):263-6. PubMed ID: 17554952
    [Abstract] [Full Text] [Related]

  • 28. Proposal for long-term protocols after Psoriasis Area and Severity Index clear with initial biologic therapy: Happily ever after with or without biologics in psoriasis therapy.
    Sano S.
    J Dermatol; 2017 Oct; 44(10):e234-e235. PubMed ID: 28623843
    [No Abstract] [Full Text] [Related]

  • 29. [Biological dermatologic agents. The Danish Society of Dermatology].
    Iversen L, Kragballe K, Dansk Dermatologisk Selskab.
    Ugeskr Laeger; 2007 Mar 19; 169(12):1100. PubMed ID: 17394811
    [No Abstract] [Full Text] [Related]

  • 30. [Therapeutic strategies against psoriasis. Skin to hide -- and how do you free your patients from it].
    Stiefelhagen P.
    MMW Fortschr Med; 2007 Sep 06; 149(35-36):12-4. PubMed ID: 17944277
    [No Abstract] [Full Text] [Related]

  • 31. Non-tuberculous mycobacterial infections in psoriasis patients treated with biologics.
    Choi YM, Adelzadeh L, Wu JJ.
    J Eur Acad Dermatol Venereol; 2016 Oct 06; 30(10):e99-e101. PubMed ID: 26388307
    [No Abstract] [Full Text] [Related]

  • 32. Effectiveness of sequential use of biologics in the treatment of moderate to severe psoriasis in real world Canadian academic clinical practice: A cohort study.
    Qiang JK, Shahbaz A, Kim W, Marinas J, Greaves S, Yeung J.
    J Am Acad Dermatol; 2016 Jan 06; 74(1):176-7. PubMed ID: 26702799
    [No Abstract] [Full Text] [Related]

  • 33. Drug survival rates for tumour necrosis factor-α antagonists in psoriasis.
    Burden AD.
    Br J Dermatol; 2011 May 06; 164(5):940-1. PubMed ID: 21518327
    [No Abstract] [Full Text] [Related]

  • 34. [Use of biologicals in psoriasis].
    Friedrich M, Philipp S, Sabat R, Asadullah K, Sterry W.
    Z Rheumatol; 2003 Oct 06; 62(5):439-49. PubMed ID: 14579031
    [Abstract] [Full Text] [Related]

  • 35. Biologics for psoriasis: more drugs, new patient categories, but fresh challenges for clinical dermatologists.
    Pink AE, Smith CH.
    Br J Dermatol; 2017 Jul 06; 177(1):7-8. PubMed ID: 28731243
    [No Abstract] [Full Text] [Related]

  • 36. Effectiveness of a new coal tar preparation in the treatment of chronic plaque-type psoriasis.
    Langner A, Wolska H, Fraczykowska M.
    Br J Clin Pract; 1989 Apr 06; 43(4):148-50. PubMed ID: 2590625
    [Abstract] [Full Text] [Related]

  • 37. Review of safety and efficacy of approved systemic psoriasis therapies.
    Kaushik SB, Lebwohl MG.
    Int J Dermatol; 2019 Jun 06; 58(6):649-658. PubMed ID: 30246393
    [Abstract] [Full Text] [Related]

  • 38. Psoriasis: more than cosmetic.
    Bren L.
    FDA Consum; 2004 Jun 06; 38(5):10-6. PubMed ID: 15595142
    [No Abstract] [Full Text] [Related]

  • 39. Curbing the psoriasis cascade. Therapies to minimize flares and frustration.
    Shenenberger DW.
    Postgrad Med; 2005 May 06; 117(5):9-16. PubMed ID: 15948363
    [Abstract] [Full Text] [Related]

  • 40. A comparison of psoriasis drug failure rates and reasons for discontinuation in biologics vs conventional systemic therapies.
    Levin AA, Gottlieb AB, Au SC.
    J Drugs Dermatol; 2014 Jul 06; 13(7):848-53. PubMed ID: 25007369
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.